Invesco Biotechnology & Genome ETF
PBE
PBE
81 hedge funds and large institutions have $64.8M invested in Invesco Biotechnology & Genome ETF in 2019 Q2 according to their latest regulatory filings, with 11 funds opening new positions, 9 increasing their positions, 29 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less ownership
Funds ownership: →
less capital invested
Capital invested by funds: $ → $
69% less repeat investments, than reductions
Existing positions increased: 9 | Existing positions reduced: 29
Holders
81
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$8.3M | |
| 2 | +$1.74M | |
| 3 | +$948K | |
| 4 |
IHL
Investment House LLC
Redondo Beach,
California
|
+$227K |
| 5 |
IWA
IBEX Wealth Advisors
Bedminster,
New Jersey
|
+$61K |
Top Sellers
| 1 | -$6.48M | |
| 2 | -$4.9M | |
| 3 | -$2.5M | |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$1.89M |
| 5 |
RJA
Raymond James & Associates
St Petersburg,
Florida
|
-$1.86M |